The use of bicyclol in the treatment of severe liver fibrosis: experimental rationale

The use of bicyclol in the treatment of severe liver fibrosis: experimental rationale

Aim. To evaluate the antifibrotic effect of bicyclol with promising clinical effects on diffuse parenchymal liver diseases.Materials and methods: We have included 40 adult male Wistar rats (weight, 180 to 200g) with experimentally inducted toxic F3 stage liver fibrosis. Control group consisted of 16...

Full description

Bibliographic Details
Main Authors: K. V. Zhdanov, A. V. Saulevich, K. V. Kozlov, S. M. Zakharenko, V. S. Sukachev, V. E. Karev, Yu. F. Zakharkiv, I. V. Potekhin, R. M. Mukhtarov, K. V. Kasianenko, S. S. Karyakin, M. G. Chernenok
Format: Article
Language:Russian
Published: Journal Infectology 2021-01-01
Series:Журнал инфектологии
Subjects:
fibrosis induction
antifibrotic
bicyclol
experiment
liver biopsy
Online Access:https://journal.niidi.ru/jofin/article/view/1149

Internet

https://journal.niidi.ru/jofin/article/view/1149

Similar Items